General Information of the Compound
Compound ID
CP0033068
Compound Name
N'-(1,1-dioxothian-4-yl)-5-ethyl-4-oxo-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide
    Show/Hide
Synonyms
GSK602
I-BRD9
compound 45 [PMID 25856009]
    Show/Hide
Structure
Formula
C22H22F3N3O3S2
Molecular Weight
497.564
Canonical SMILES
CCn1cc(-c2cccc(c2)C(F)(F)F)c2sc(cc2c1=O)C(=N)NC1CCS(=O)(=O)CC1
    Show/Hide
InChI
InChI=1S/C22H22F3N3O3S2/c1-2-28-12-17(13-4-3-5-14(10-13)22(23,24)25)19-16(21(28)29)11-18(32-19)20(26)27-15-6-8-33(30,31)9-7-15/h3-5,10-12,15H,2,6-9H2,1H3,(H2,26,27)
    Show/Hide
InChIKey
WRUWGLUCNBMGPS-UHFFFAOYSA-N
Physicochemical Property
logP
4.26087
Rotatable Bonds
4
Heavy Atom Count
33
Polar Areas
92.02
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
33

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 91668541
ChEMBL ID
CHEMBL3769507
Clinical Information about the Compound
Drug 1 ( I-BRD9 )
Drug Name I-BRD9
Target(s)
Bromodomain-containing protein 9 (BRD9)
Inhibitor